Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander I van Leuven

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
The Journal of Rheumatology|August 1, 2023
Are Patients With Systemic Sclerosis Subject to an Increased Risk of Developing Superficial Erosion of Atherosclerotic Plaques?Sander I van Leuven
Expert Opinion on Pharmacotherapy|June 17, 2005
AtorvastatinSander I van Leuven, John J P Kastelein
Annals of Medicine|July 9, 2008
High-density lipoprotein: a fall from grace?Sander I van Leuven, Erik S Stroes, John J P Kastelein
Rheumatology (Oxford, England)|November 19, 2020
Feasibility of online home spirometry in systemic sclerosis-associated interstitial lung disease: a pilot studyCatharina C Moor, Sander I van Leuven, Marlies S Wijsenbeek, et al.
Current Pharmaceutical Design|April 14, 2007
Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?Fatima Akdim, Sander I van Leuven, John J P Kastelein, et al.
Current Opinion in Lipidology|November 11, 2006
The dyslipidemia of chronic renal disease: effects of statin therapyRiza C Ozsoy, Sander I van Leuven, John J P Kastelein, et al.
Annals of the Rheumatic Diseases|November 12, 2010
Statin therapy in lupus-mediated atherogenesis: two birds with one stone?Sander I van Leuven, Yanice V Mendez-Fernandez, Erik S Stroes, et al.
Cardiovascular Research|November 18, 2005
Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles?Sander I van Leuven, John J P Kastelein, Anthony C Allison, et al.
Current Opinion in Lipidology|September 9, 2005
Cardiovascular disease in systemic lupus erythematosus: has the time for action come?Sander I van Leuven, John J P Kastelein, Michael R Hayden, et al.
Current Opinion in HIV and AIDS|April 18, 2009
Atherosclerotic vascular disease in HIV: it is not just antiretroviral therapy that hurts the heart!Sander I van Leuven, Raaj R Sankatsing, Joost N Vermeulen, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Rheumatology|August 1, 2023
Are Patients With Systemic Sclerosis Subject to an Increased Risk of Developing Superficial Erosion of Atherosclerotic Plaques?Sander I van Leuven
Expert Opinion on Pharmacotherapy|June 17, 2005
AtorvastatinSander I van Leuven, John J P Kastelein
Annals of Medicine|July 9, 2008
High-density lipoprotein: a fall from grace?Sander I van Leuven, Erik S Stroes, John J P Kastelein
Rheumatology (Oxford, England)|November 19, 2020
Feasibility of online home spirometry in systemic sclerosis-associated interstitial lung disease: a pilot studyCatharina C Moor, Sander I van Leuven, Marlies S Wijsenbeek, et al.
Current Pharmaceutical Design|April 14, 2007
Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?Fatima Akdim, Sander I van Leuven, John J P Kastelein, et al.
Current Opinion in Lipidology|November 11, 2006
The dyslipidemia of chronic renal disease: effects of statin therapyRiza C Ozsoy, Sander I van Leuven, John J P Kastelein, et al.
Annals of the Rheumatic Diseases|November 12, 2010
Statin therapy in lupus-mediated atherogenesis: two birds with one stone?Sander I van Leuven, Yanice V Mendez-Fernandez, Erik S Stroes, et al.
Cardiovascular Research|November 18, 2005
Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles?Sander I van Leuven, John J P Kastelein, Anthony C Allison, et al.
Current Opinion in Lipidology|September 9, 2005
Cardiovascular disease in systemic lupus erythematosus: has the time for action come?Sander I van Leuven, John J P Kastelein, Michael R Hayden, et al.
Current Opinion in HIV and AIDS|April 18, 2009
Atherosclerotic vascular disease in HIV: it is not just antiretroviral therapy that hurts the heart!Sander I van Leuven, Raaj R Sankatsing, Joost N Vermeulen, et al.
Pageof 4